Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Jun 30, 2023 (Letter of inquiry)

Later deadlines: Jul 31, 2023 (Full proposal)

Grant amount: Up to US $52,000,000

Funding uses: Research, Training / Capacity Building

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

This Funding Opportunity Announcement (FOA) invites applications for the Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform initiative. This Platform aims to transform the AD/ADRD research enterprise by serving as a central hub of research access that aims to: 

• improve applicability and generalizability of findings through larger datasets that include more diverse populations;
• capture more complete information through linking a variety of data sources;
• increase the speed at which scientific questions can be answered; and
• improve researchers ability to answer questions that cannot be feasibly or readily answered via clinical trial.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.